Skip to Main Content

Scheduled Maintenance: CDAS will be undergoing maintenance on Saturday, January 3^rd from 7:30 AM to 9:30 AM U.S. Eastern Standard Time for updates to the website. During this time you may experience intermittent downtime..

Browse Lab Results > 2016-0041

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Phase 3 validation of early detection biomarker panel for pancreatic cancer

Datasets

2016-0041 Primary

Site: Pancreas

Inclusion Criteria:

No Prior History of Pancreatic Cancer
No history of any cancer before trial and rare cancer during trial (Controls)
UCLA Serum and EDTA Plasma Available
Pre-Dx UCLA Serum and EDTA Plasma Available

Matching Factors:

Gender
Age level
Race
Study Year of Blood Draw
Date of Draw (+/- 365 days)

Match Ratio: 2:1

Match Technique: Individual matching without replacement only cases as controls.

Analytes:

Cancer Antigen 19-9
Thrombospondin-2

Number of Cases: 238

Number of Controls: 476

Site: Pancreas

Inclusion Criteria:

No Prior History of Pancreatic Cancer
No history of any cancer before trial and rare cancer during trial (Controls)
UCLA Serum and EDTA Plasma Available
Pre-Dx UCLA Serum and EDTA Plasma Available

Matching Factors:

Gender
Age level
Race
Study Year of Blood Draw
Date of Draw (+/- 365 days)

Match Ratio: 2:1

Match Technique: Individual matching without replacement only cases as controls.

Analytes:

Cancer Antigen 19-9
Thrombospondin-2

Number of Cases: 238

Number of Controls: 476